Analysts' average 12-month price target for MerckInc is $140.
Get informed when a big investor buys or sells
+ Follow$135.97
13 analysts in the last 4 months
High: $155 | Low: $105
No recommendations in the last 4 months.
MerckInc (MRK) currently reports a target price of $140. Use the charts on this page to explore MerckInc's target price history and peer comparisons.
Analysts' average 12-month price target for MerckInc is $140, about 1.3% upside from the current share price of $135.97. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $140, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MerckInc, and consider following MRK for alerts when major investors trade the stock.
MerckInc is classified in the Healthcare sector. On target price, it currently shows $140. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MRK with unrelated industries.